inforMED
PZMClass II

Next Generation Sequencing Based Tumor Profiling Test

Pathology · 21 CFR 866.6080

A next-generation sequencing based tumor profiling test is a qualitative in vitro diagnostic test intended to detect mutations in a broad panel of targeted genes that are somatically altered in malignant neoplasms from tumor specimens obtained from patients diagnosed with malignant solid neoplasms using targeted next-generation sequencing.

MDR events0All time
Recalls0All time
Registered firms6Currently listed
510(k) clearances8All time

Recent MDR events

0 adverse event reports on file

See all →

No MDR events on file for this product code.

Event type breakdown

No data available.

Most-reported manufacturers

See all →

No data available.

Recalls

0 recall events for this product code

See all →

No recalls on file for this product code.